# 1st Gen Model Boston Scientific Corporation Surgical & medical instruments
July 24, 2017
at 21-jul-2017
-
Top 20 Return
BSX
Model's trade recommendations 0.62% Return for period
8.97% Annual return
$38.25B Market Cap
β 1.10
BSX
Model (following trade recommendations)BSX
Underlying stockS&P 500
Index- STRONG BUY Analysts consensus recommendation
Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.
Industry sector: Medical
Sector classification: Surgical & medical instruments
Deep Learning based analysis and prediction model for Boston Scientific Corporation (BSX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Sept. 30, 2015.
Market data for BSX model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
| Float | 1359M |
| P/E | 24.72 |
| Shares Outstanding | 1369M |
| % Held by Insiders | 0.74% |
| % Held by Institutions | 91.87% |
| EPS (last reported FY) | $1.11 |
| EPS (last reported Q) | $0.29 |
| EPS, estimated (last reported Q) | $0.30 |
| Total revenues | $8 B |
| Net income | $0 B |